Back to search

Article

Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy

2026-02-24

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> There is a need for novel therapies for diabetic retinopathy (DR) because existing therapies treat only certain features of DR and do not work optimally for all patients. While proteomic studies provide insight into disease pathobiology, they are often limited to small sample sizes due to high costs, limiting their generalizability and reproducibility. Moreover, they often yiel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b44d8a30-64fd-5bba-be47-d8d98bfdb035
DOI
10.64898/2026.02.23.26346903
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathyDOI 10.64898/2026.02.23.26346903
Select a neighboring publication to make it the new centre.